Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2003 3
2004 3
2005 6
2006 10
2007 6
2008 6
2009 8
2010 6
2011 9
2012 7
2013 7
2014 11
2015 5
2016 7
2017 7
2018 4
2019 5
2020 8
2021 5
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Ye D, Agerbaek M, Enting D, McDermott R, Gajate P, Peer A, Milowsky MI, Nosov A, Neif Antonio J Jr, Tupikowski K, Toms L, Fischer BS, Qureshi A, Collette S, Unsal-Kacmaz K, Broughton E, Zardavas D, Koon HB, Galsky MD. Bajorin DF, et al. Among authors: koon hb. N Engl J Med. 2021 Jun 3;384(22):2102-2114. doi: 10.1056/NEJMoa2034442. N Engl J Med. 2021. PMID: 34077643 Free PMC article. Clinical Trial.
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas.
Rambhia PH, Reichert B, Scott JF, Feneran AN, Kazakov JA, Honda K, Koon H, Gerstenblith MR. Rambhia PH, et al. Among authors: koon h. Int J Clin Oncol. 2019 Oct;24(10):1171-1181. doi: 10.1007/s10147-019-01490-2. Epub 2019 Jul 18. Int J Clin Oncol. 2019. PMID: 31321613 Review.
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Bajorin DF, Witjes JA, Gschwend JE, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Ye D, Agerbaek M, Enting D, McDermott R, Gajate P, Peer A, Milowsky MI, Nosov A, Antonio JN Jr, Tupikowski K, Toms L, Fischer BS, Qureshi A, Collette S, Unsal-Kacmaz K, Broughton E, Zardavas D, Koon HB, Galsky MD. Bajorin DF, et al. Among authors: koon hb. Future Oncol. 2023 Feb;19(6):413-426. doi: 10.2217/fon-2022-1294. Epub 2023 Mar 15. Future Oncol. 2023. PMID: 36919916 Free article. Review.
Update on primary mucosal melanoma.
Tacastacas JD, Bray J, Cohen YK, Arbesman J, Kim J, Koon HB, Honda K, Cooper KD, Gerstenblith MR. Tacastacas JD, et al. Among authors: koon hb. J Am Acad Dermatol. 2014 Aug;71(2):366-75. doi: 10.1016/j.jaad.2014.03.031. Epub 2014 May 6. J Am Acad Dermatol. 2014. PMID: 24815565 Review.
Antimicrobial peptides and colitis.
Ho S, Pothoulakis C, Koon HW. Ho S, et al. Among authors: koon hw. Curr Pharm Des. 2013;19(1):40-7. doi: 10.2174/13816128130108. Curr Pharm Des. 2013. PMID: 22950497 Free PMC article. Review.
Current systemic therapies for melanoma.
Palathinkal DM, Sharma TR, Koon HB, Bordeaux JS. Palathinkal DM, et al. Among authors: koon hb. Dermatol Surg. 2014 Sep;40(9):948-63. doi: 10.1097/01.DSS.0000452626.09513.55. Dermatol Surg. 2014. PMID: 25072125 Review.
Anti-CD30 antibody-based therapy.
Koon HB, Junghans RP. Koon HB, et al. Curr Opin Oncol. 2000 Nov;12(6):588-93. doi: 10.1097/00001622-200011000-00012. Curr Opin Oncol. 2000. PMID: 11085459 Review.
Mice expressing fluorescent PAR2 reveal that endocytosis mediates colonic inflammation and pain.
Latorre R, Hegron A, Peach CJ, Teng S, Tonello R, Retamal JS, Klein-Cloud R, Bok D, Jensen DD, Gottesman-Katz L, Rientjes J, Veldhuis NA, Poole DP, Schmidt BL, Pothoulakis CH, Rankin C, Xie Y, Koon HW, Bunnett NW. Latorre R, et al. Among authors: koon hw. Proc Natl Acad Sci U S A. 2022 Feb 8;119(6):e2112059119. doi: 10.1073/pnas.2112059119. Proc Natl Acad Sci U S A. 2022. PMID: 35110404 Free PMC article.
127 results